Cargando…

Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity

A preterm infant with zone 1 aggressive posterior retinopathy of prematurity developed infectious endophthalmitis after intravitreal injection of ranibizumab. Urgent empirical intravitreal therapy with vancomycin, ceftazidime, and dexamethasone along with intravenous therapy with amikacin and merope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandra, Parijat, Kumawat, Devesh, Tewari, Ruchir, Azimeera, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552608/ https://www.ncbi.nlm.nih.gov/pubmed/31124535 http://dx.doi.org/10.4103/ijo.IJO_884_17

Ejemplares similares

Retinopathy of prematurity in oculocutaneous albinism
por: Chandra, Parijat, et al.
Publicado: (2019)

Hybrid clear corneal micro-incision surgical technique for stage 5 retinopathy of prematurity
por: Chandra, Parijat, et al.
Publicado: (2019)

Surgical outcomes of immediate sequential bilateral vitreoretinal surgery for advancing retinopathy of prematurity
por: Chandra, Parijat, et al.
Publicado: (2019)

The restless retina in aggressive posterior retinopathy of prematurity: prevention is better than cure
por: Chandra, Parijat, et al.
Publicado: (2018)

The restless retina in aggressive posterior retinopathy of prematurity: prevention is better than cure
por: Chandra, Parijat, et al.
Publicado: (2017)

Short-term incidence and management of glaucoma after successful surgery for stage 4 retinopathy of prematurity
por: Chandra, Parijat, et al.
Publicado: (2019)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016)

Posterior laser barrage in advancing retinopathy of prematurity: A prospective randomized study
por: Tewari, Ruchir, et al.
Publicado: (2019)

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
por: Xu, Yu, et al.
Publicado: (2016)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012)

Ocular auto-stimulation and its morbidity in stage 5 retinopathy of prematurity
por: Kumawat, Devesh, et al.
Publicado: (2019)

Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
por: Suren, Elcin, et al.
Publicado: (2020)

Bilateral proliferative retinopathy in B-cell acute lymphoblastic leukemia
por: Kumawat, Devesh, et al.
Publicado: (2018)

Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab
por: Tong, Qizhe, et al.
Publicado: (2018)

Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity
por: Gangwe, Anil Babanrao, et al.
Publicado: (2021)

Aggressive Posterior Retinopathy of Prematurity in a Premature Male Infant
por: Zhou, Jun, et al.
Publicado: (2017)

Asymmetric retinopathy of prematurity in presumed fungal endophthalmitis
por: Al-khersan, Hasenin, et al.
Publicado: (2020)

Macular Development in Aggressive Posterior Retinopathy of Prematurity
por: Pandya, Hemang K., et al.
Publicado: (2015)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
por: Blair, Michael, et al.
Publicado: (2018)

Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection
por: Kugu, Suleyman, et al.
Publicado: (2012)

Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection
por: Joshi, Lavnish, et al.
Publicado: (2012)

Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity
por: Cao, Jing-Ke, et al.
Publicado: (2023)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019)

Severe Gemella haemolysans endophthalmitis following ranibizumab intravitreal injection
por: Salceanu, Silvia Olivia, et al.
Publicado: (2017)

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis(®))
por: Horowitz, Soraya Alessandra, et al.
Publicado: (2020)

Comprehensive Retinal Image Analysis for Aggressive Posterior Retinopathy of Prematurity
por: Rajashekar, Deepthi, et al.
Publicado: (2016)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Up close with the vascular loops in aggressive posterior retinopathy of prematurity
por: Raju, Biju, et al.
Publicado: (2019)

Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
por: Abdel Salam Gomaa, Nancy, et al.
Publicado: (2021)

Effect of ranibizumab on retinopathy of prematurity: A meta-analysis
por: Wang, Zhibin, et al.
Publicado: (2022)

Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial
por: Tawfik, Ghada Mahmoud, et al.
Publicado: (2022)

Profile of asymmetrical retinopathy of prematurity in twins
por: Azad, Rajvardhan, et al.
Publicado: (2010)

Retinopathy of prematurity: Addressing the emerging burden in developing countries
por: Senjam, Suraj Singh, et al.
Publicado: (2020)

Aggressive posterior retinopathy of prematurity in infants ≥1500 g birth weight
por: Sanghi, Gaurav, et al.
Publicado: (2014)

Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment
por: Narnaware, Shilpi H, et al.
Publicado: (2021)

Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity
por: Patel, Samir N, et al.
Publicado: (2019)

Efficacy of a biosimilar ranibizumab monotherapy for the treatment of retinopathy of prematurity
por: Prajapati, Vipul, et al.
Publicado: (2023)

Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
por: Alva, Niza, et al.
Publicado: (2023)

COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY
por: Zhang, Guoming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r8cq80cde9ga9v1cp9397euk9o